Evidence for the involvement of presynaptic cholinergic functions in tolerance to diisopropylfluorophosphate
- PMID: 3660413
- DOI: 10.1016/0041-008x(87)90139-6
Evidence for the involvement of presynaptic cholinergic functions in tolerance to diisopropylfluorophosphate
Abstract
Rats were treated with diisopropylfluorophosphate (DFP) acutely or daily for 14 days. The involvement of various presynaptic and postsynaptic functions of the cholinergic system in the development of tolerance to DFP was studied. Receptor density and affinity of both muscarinic and nicotinic receptors, high-affinity choline uptake, and [K+]-evoked release of acetylcholine (ACh) by atropine were not changed after acute administration of 2 mg/kg DFP. Both muscarinic and nicotinic receptors were down-regulated to the same extent (40-50%) after subacute administration of DFP (1 mg/kg) without changes in their affinities. Binding sites of muscarinic receptors were maximally decreased after 7 days of DFP administration. Thereafter, they remained constant throughout 14 days of administration. One hour after the last injection of 2 mg/kg DFP to subacutely treated rats, the maximum velocity of high-affinity choline uptake was significantly decreased in the striatum (33%) and hippocampus (53%) without changes in Km values. Twenty-four hours after the last injection of DFP, only a higher dose of DFP (2 mg/kg) significantly inhibited choline uptake. Potassium-evoked release of ACh by slices of striatum was not different between acutely and subacutely treated rats. However, the release of ACh by slices of striatum and hippocampus was significantly increased by atropine in subacutely treated rats. It is suggested that along with the down-regulation of the postsynaptic receptors, subsensitivity of presynaptic functions of the cholinergic synapse also develops during subacute administration of DFP.
Similar articles
-
Changes in ACh levels in the rat brain during subacute administration of diisopropylfluorophosphate.Toxicol Appl Pharmacol. 1987 Sep 30;90(3):477-89. doi: 10.1016/0041-008x(87)90140-2. Toxicol Appl Pharmacol. 1987. PMID: 3660414
-
Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.J Pharmacol Exp Ther. 1983 Aug;226(2):519-25. J Pharmacol Exp Ther. 1983. PMID: 6875862
-
Contractile responses of tracheal smooth muscle in organophosphate-treated swine: 1. Agonist changes.J Auton Pharmacol. 1988 Jun;8(2):93-106. doi: 10.1111/j.1474-8673.1988.tb00173.x. J Auton Pharmacol. 1988. PMID: 2902099
-
Mechanisms of facilitation and muscarinic or alpha-adrenergic inhibition of acetylcholine and noradrenaline secretion from peripheral nerves.Acta Physiol Scand Suppl. 1982;506:1-39. Acta Physiol Scand Suppl. 1982. PMID: 6293252 Review.
-
Biological functions of keratinocyte cholinergic receptors.J Investig Dermatol Symp Proc. 1997 Aug;2(1):41-8. doi: 10.1038/jidsymp.1997.10. J Investig Dermatol Symp Proc. 1997. PMID: 9487015 Review.